Menu Search
Equities

Sandoz Group AG

SDZ:SWX

Sandoz Group AG

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CHF)39.65
  • Today's Change-0.22 / -0.55%
  • Shares traded769.38k
  • 1 Year change+50.76%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 16:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy4
Outperform7
Hold4
Sell0
Strong Sell0

Share price forecast in USD

The 14 analysts offering 12 month price targets for Sandoz Group AG have a median target of 41.15, with a high estimate of 49.90 and a low estimate of 34.93. The median estimate represents a 3.78% increase from the last price of 39.65.
High25.9%49.90
Med3.8%41.15
Low-11.9%34.93

Dividends

In 2023, Sandoz Group AG reported a dividend of 0.53 USD. The 14 analysts covering the company expect dividends of 0.64 USD for the upcoming fiscal year, an increase of 19.12%.
Div growth (TTM)--
More ▼

Earnings history & estimates in USD

Sandoz Group AG reported annual 2023 earnings of 2.20 per share on Mar 20, 2024.
More ▼

Revenue history & estimates in USD

of 2.54bn. This bettered the 2.50bn estimate of the one analyst covering the company. The same period last year the company did not report revenues.
Sandoz Group AG had revenues for the full year 2023 of 9.65bn. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.